Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Journal of hematology & oncology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Myeloma%22&type=Subject&filter%5B%5D=journalStr%3A%22Journal+of+hematology+%26+oncology%22
/vufind/Search/Results?lookfor=%22Myeloma%22&type=Subject&filter%5B%5D=journalStr%3A%22Journal+of+hematology+%26+oncology%22
Search /vufind/Search2/Results?lookfor=%22Myeloma%22&type=Subject&filter%5B%5D=journalStr%3A%22Journal+of+hematology+%26+oncology%22
PubPharm (208)
1
Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells : 5-year follow-up of the LEGEND-2 trial
enthalten in:
Journal of hematology & oncology
| 2024
von
Xu, J.
|
Wang, B.
|
Yu, S.
| +10
Wird geladen...
2
Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial
enthalten in:
Journal of hematology & oncology
| 2024
von
Xu, J.
|
Wang, B.
|
Yu, S.
| +10
Wird geladen...
3
Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy : latest updates from ASCO 2023 Annual Meeting
enthalten in:
Journal of hematology & oncology
| 2023
von
Zhao, J.
|
Ren, Q.
|
Liu, X.
| +2
Wird geladen...
4
Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting
enthalten in:
Journal of hematology & oncology
| 2023
von
Zhao, J.
|
Ren, Q.
|
Liu, X.
| +2
Wird geladen...
5
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
enthalten in:
Journal of hematology & oncology
| 2023
von
Rejeski, K.
|
Hansen, D.
|
Bansal, R.
| +15
Wird geladen...
6
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
enthalten in:
Journal of hematology & oncology
| 2023
von
Rejeski, K.
|
Hansen, D.
|
Bansal, R.
| +15
Wird geladen...
7
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
enthalten in:
Journal of hematology & oncology
| 2023
von
Rejeski, K.
|
Hansen, D.
|
Bansal, R.
| +15
Wird geladen...
8
Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
enthalten in:
Journal of hematology & oncology
| 2023
von
Lopez-Muñoz, N.
|
Hernández-Ibarburu, G.
|
Alonso, R.
| +14
ErratumIn: J Hematol Oncol. 2023 Jul 25;16(1):81. - PMID 37491311
Wird geladen...
9
Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
enthalten in:
Journal of hematology & oncology
| 2023
von
Lopez-Muñoz, N.
|
Hernández-Ibarburu, G.
|
Alonso, R.
| +14
Wird geladen...
10
Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
enthalten in:
Journal of hematology & oncology
| 2023
von
Lopez-Muñoz, N.
|
Hernández-Ibarburu, G.
|
Alonso, R.
| +14
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Journal of hematology & oncology
Medienart
208
Aufsätze
208
E-Artikel
208
E-Ressourcen
Zeitschriftentitel
Journal of hematology & oncology
Thema
156
Multiple myeloma
57
Journal Article
56
Research Support, Non-U.S. Gov't
27
Myeloma
21
Bortezomib
19
Review
17
Letter
17
Multiple Myeloma
14
Lenalidomide
13
Immunotherapy
13
Lymphoma
13
Research Support, N.I.H., Extramural
12
Drug resistance
11
Receptors, Chimeric Antigen
10
Chimeric antigen receptor
10
Leukemia
9
B-Cell Maturation Antigen
9
CD38
8
Antineoplastic Agents
8
BCMA
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
94
2020-
106
2010-2019
8
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
208
Englisch
Haven't found what you're looking for?
Wird geladen...